CareDx, Inc (CDNA)
USD 15.0
(-0.46%)
USD 15.0
(-0.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 280.32 Million USD | -12.89% |
| 2022 | 321.79 Million USD | 8.57% |
| 2021 | 296.39 Million USD | 54.22% |
| 2020 | 192.19 Million USD | 51.25% |
| 2019 | 127.06 Million USD | 65.95% |
| 2018 | 76.56 Million USD | 58.45% |
| 2017 | 48.32 Million USD | 18.93% |
| 2016 | 40.63 Million USD | 44.37% |
| 2015 | 28.14 Million USD | 3.07% |
| 2014 | 27.3 Million USD | 23.57% |
| 2013 | 22.09 Million USD | 8.05% |
| 2012 | 20.45 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 82.88 Million USD | -10.18% |
| 2024 Q2 | 92.27 Million USD | 28.07% |
| 2024 Q1 | 72.04 Million USD | 9.88% |
| 2023 Q1 | 77.26 Million USD | -6.22% |
| 2023 Q2 | 70.3 Million USD | -9.01% |
| 2023 Q4 | 65.56 Million USD | -2.42% |
| 2023 Q3 | 67.19 Million USD | -4.42% |
| 2023 FY | 280.32 Million USD | -12.89% |
| 2022 Q4 | 82.38 Million USD | 3.81% |
| 2022 FY | 321.79 Million USD | 8.57% |
| 2022 Q1 | 79.41 Million USD | 0.25% |
| 2022 Q2 | 80.63 Million USD | 1.53% |
| 2022 Q3 | 79.35 Million USD | -1.58% |
| 2021 FY | 296.39 Million USD | 54.22% |
| 2021 Q1 | 67.4 Million USD | 14.93% |
| 2021 Q4 | 79.22 Million USD | 4.8% |
| 2021 Q3 | 75.58 Million USD | 1.89% |
| 2021 Q2 | 74.18 Million USD | 10.07% |
| 2020 Q2 | 41.8 Million USD | 8.91% |
| 2020 FY | 192.19 Million USD | 51.25% |
| 2020 Q1 | 38.38 Million USD | 7.14% |
| 2020 Q4 | 58.64 Million USD | 9.88% |
| 2020 Q3 | 53.36 Million USD | 27.67% |
| 2019 Q4 | 35.82 Million USD | 5.94% |
| 2019 Q2 | 31.45 Million USD | 21.06% |
| 2019 FY | 127.06 Million USD | 65.95% |
| 2019 Q1 | 25.98 Million USD | 10.52% |
| 2019 Q3 | 33.81 Million USD | 7.49% |
| 2018 Q4 | 23.5 Million USD | 10.98% |
| 2018 FY | 76.56 Million USD | 58.45% |
| 2018 Q3 | 21.18 Million USD | 18.86% |
| 2018 Q2 | 17.82 Million USD | 26.83% |
| 2018 Q1 | 14.05 Million USD | 12.4% |
| 2017 Q1 | 11.58 Million USD | 6.67% |
| 2017 FY | 48.32 Million USD | 18.93% |
| 2017 Q4 | 12.5 Million USD | 2.56% |
| 2017 Q3 | 12.19 Million USD | 1.2% |
| 2017 Q2 | 12.04 Million USD | 3.99% |
| 2016 Q2 | 10.7 Million USD | 63.18% |
| 2016 Q1 | 6.56 Million USD | -1.29% |
| 2016 FY | 40.63 Million USD | 44.37% |
| 2016 Q3 | 12.47 Million USD | 16.5% |
| 2016 Q4 | 10.86 Million USD | -12.95% |
| 2015 Q1 | 7.21 Million USD | -9.26% |
| 2015 FY | 28.14 Million USD | 3.07% |
| 2015 Q4 | 6.64 Million USD | -7.03% |
| 2015 Q3 | 7.15 Million USD | 0.31% |
| 2015 Q2 | 7.12 Million USD | -1.21% |
| 2014 FY | 27.3 Million USD | 23.57% |
| 2014 Q2 | 6.77 Million USD | 14.38% |
| 2014 Q4 | 7.95 Million USD | 19.51% |
| 2014 Q3 | 6.65 Million USD | -1.8% |
| 2014 Q1 | 5.92 Million USD | 1.18% |
| 2013 Q3 | 5.8 Million USD | 6.38% |
| 2013 Q1 | 4.98 Million USD | 0.0% |
| 2013 FY | 22.09 Million USD | 8.05% |
| 2013 Q2 | 5.45 Million USD | 9.56% |
| 2013 Q4 | 5.85 Million USD | 0.86% |
| 2012 FY | 20.45 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -797.066% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -1997.065% |
| Aspira Women's Health Inc. | 9.15 Million USD | -2962.312% |
| Biodesix, Inc. | 49.08 Million USD | -471.076% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -2768.996% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -10969.067% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -10969.067% |
| Bionano Genomics, Inc. | 36.11 Million USD | -676.177% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 219.78 Million USD | -27.543% |
| DarioHealth Corp. | 20.35 Million USD | -1277.378% |
| Exact Sciences Corporation | 2.49 Billion USD | 88.786% |
| Fulgent Genetics, Inc. | 289.21 Million USD | 3.074% |
| Guardant Health, Inc. | 563.94 Million USD | 50.293% |
| ICON Public Limited Company | 8.12 Billion USD | 96.548% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 92.343% |
| Illumina, Inc. | 4.5 Billion USD | 93.776% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -8908.475% |
| iSpecimen Inc. | 9.92 Million USD | -2723.517% |
| Standard BioTools Inc. | 106.34 Million USD | -163.611% |
| MDxHealth SA | 70.19 Million USD | -299.362% |
| 23andMe Holding Co. | 219.63 Million USD | -27.63% |
| Medpace Holdings, Inc. | 1.88 Billion USD | 85.135% |
| Myriad Genetics, Inc. | 678.4 Million USD | 58.679% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -31204.363% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| NeoGenomics, Inc. | 591.64 Million USD | 52.619% |
| Neogen Corporation | 924.22 Million USD | 69.669% |
| Inotiv, Inc. | 572.42 Million USD | 51.029% |
| Natera, Inc. | 1.08 Billion USD | 74.106% |
| OPKO Health, Inc. | 863.49 Million USD | 67.536% |
| Psychemedics Corporation | 22.09 Million USD | -1168.549% |
| Prenetics Global Limited | 21.74 Million USD | -1189.28% |
| Prenetics Global Limited | 21.74 Million USD | -1189.28% |
| Precipio, Inc. | 15.19 Million USD | -1744.601% |
| Personalis, Inc. | 73.48 Million USD | -281.492% |
| RadNet, Inc. | 1.61 Billion USD | 82.66% |
| Sera Prognostics, Inc. | 306 Thousand USD | -91509.15% |
| Sotera Health Company | 1.04 Billion USD | 73.284% |
| Neuronetics, Inc. | 71.34 Million USD | -292.897% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -512.262% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -512.262% |
| Trinity Biotech plc | 56.83 Million USD | -393.25% |
| Twist Bioscience Corporation | 312.97 Million USD | 10.432% |
| Exagen Inc. | 52.54 Million USD | -433.463% |